← Back to Search

Advance Care Planning Discussions for Bone Marrow Transplant Patients

N/A

Recruiting

Led By Lori Wiener, Ph.D.

Research Sponsored by National Cancer Institute (NCI)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up follow-up (week 4-9)

Awards & highlights

Study Summary

This trial will study how AYAs with life-threatening illnesses, and their caregivers, benefit from discussing their care values and priorities with a team member before HSCT.

Who is the study for?

This study is for young adults aged 18 to 39 who are about to receive a bone marrow transplant and have enrolled in an NIH study. They must speak English and be able to give informed consent. A caregiver over the age of 18, identified by the patient, can also join. Healthcare providers involved in their care may participate too.Check my eligibility

What is being tested?

The trial explores whether discussions on advance care planning (ACP) benefit young patients undergoing stem cell transplants and their caregivers. It involves completing questionnaires and having three detailed conversations about treatment expectations, personal values, support needs, and documenting care preferences.See study design

What are the potential side effects?

Since this trial focuses on conversations rather than medical treatments or drugs, there are no direct physical side effects. However, these discussions might evoke emotional responses due to the sensitive nature of topics like end-of-life care decisions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ follow-up (week 4-9)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~follow-up (week 4-9)

This trial's timeline: 3 weeks for screening, Varies for treatment, and follow-up (week 4-9) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability, Emotional impact of intervention

Acceptability, Timing of intervention

Acceptability, qualitative interview

+1 more

Secondary outcome measures

Communication quality

Concordance of rankings

Concordance of ratings

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: 1 / Assessments and ConversationExperimental Treatment1 Intervention

Baseline and follow-up assessments and conversations at three timepoints

Group II: 2 / SurveyActive Control1 Intervention

Following each AYA/caregiver dyad s completion of timepoint 3, a one-time survey will be sent to a primary clinical attending and APPs who cared for the AYA during the study period

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)Lead Sponsor

13,665 Previous Clinical Trials

40,925,734 Total Patients Enrolled

Lori Wiener, Ph.D.Principal InvestigatorNational Cancer Institute (NCI)

6 Previous Clinical Trials

1,054 Total Patients Enrolled

Media Library

1 / Assessments and Conversation Clinical Trial Eligibility Overview. Trial Name: NCT05605574 — N/A

Bone Marrow Transplant Research Study Groups: 2 / Survey, 1 / Assessments and Conversation

Bone Marrow Transplant Clinical Trial 2023: 1 / Assessments and Conversation Highlights & Side Effects. Trial Name: NCT05605574 — N/A

1 / Assessments and Conversation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05605574 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this experiment?

"Indeed. The records on clinicaltrials.gov demonstrate that this study is actively enrolling participants, having gone online November 16th 2022 with a recent update 18 days later. Presently the investigation necessitates 120 volunteers from one healthcare facility."

Answered by AI

How many participants are involved in this experiment?

"Affirmative. Per the clinicaltrials.gov page, this clinical trial is actively recruiting participants and opened on November 16th 2022 with a recent update posted on November 18th 2022. It requires 120 candidates to be enrolled at just one medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

2022. "Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05605574.